2650. Evaluating Antiviral Agents for Human Noroviruses Using a Human Intestinal Enteroid Model

BACKGROUND: Norovirus can cause chronic infections with serious morbidity and mortality in immunocompromised patients. While there are no FDA-approved medications for these infections, nitazoxanide, ribavirin, and enterally administered pooled immunoglobulin (IVIG) are used off-label on the basis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortes-Penfield, Nicolas W, Ramani, Sasirekha, Neill, Frederick, Ettayebi, Khalil, Atmar, Robert, Estes, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809658/
http://dx.doi.org/10.1093/ofid/ofz360.2328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809658/
http://dx.doi.org/10.1093/ofid/ofz360.2328

Ejemplares similares